Frank Donatelli, executive vice president and director of federal public affairs for McGuireWoods Consulting and counsel with McGuireWoods LLP, wrote the following article that was published in U.S. News & World Report.
McGuireWoods Consulting announced today it has opened a Tallahassee office with the arrival of veteran lobbyists Sean Stafford, Rhett O’Doski and Ryder Rudd.
Tucker Martin will join the MWCAdvocacy team next week as a senior vice president, assisting clients across a variety of industries nationwide with media relations, strategic communications, and grassroots initiatives.
McGuireWoods Consulting is delighted to announce the return of Missy Neff to its Richmond team as a senior vice president for MWCAdvocacy, handling legislative affairs. As part of the MWCAdvocacy team, she will support clients along with a team of additional communications, grassroots, and digital professionals.
This Week: House and Senate Work to Avoid Government Shutdown; Legislation on Gag Clauses Moving; Oral Arguments on ACA Individual Mandate Court Case Held
Your weekly North Carolina political news report.
This week: Senate Commerce Committee advances science and technology policy nominees, House and Senate Committees question social media executives, net neutrality still controversial, House Panel discusses apprenticeship expansion
This week: House Committee to look at emerging transportation technologies, congress intensifying its response to robocalls and California passes initial revisions to new privacy law.
This Week: The House and Senate return for final action before midterm elections. The House has only 11 legislative days left. Appropriations and opioid legislation are among the must-do items.
An overview of the upcoming week in Congress from the McGuireWoods Consulting Federal Public Affairs Team.
The Centers for Medicare and Medicaid Services (CMS) recently proposed to expand its site-neutral payment policy to clinic visits.
The House of Representatives approved the first major change to federal regulation of the over-the-counter drug industry in 40 years.